Vaccine with syringe
Industries

Cell & Gene Therapy

Developing and launching a successful cell and gene therapy requires specialist expertise and out-of-the-box thinking to adapt to new business models and pricing strategies. CRA has significant experience in this space and understands the unique challenges that gene or cell therapies can bring to manufacturers and the healthcare industry. We bring industry-leading methodologies from clinical development through launch to support commercial, medical affairs, pricing, market access, and policy makers/regulators in navigating a rapidly evolving landscape.

Our offerings

We are gene therapy specialists.

CRA’s experience stems from more than 100 gene therapy engagements across multiple therapeutic areas.

  • 50+
    Gene therapy engagements since 2022
  • 20+
    Disease areas covered

Engagements

  • 01
    Navigating and segmenting the rare disease market in the evolving hepatology landscape
    Client issue A leading pharmaceutical company approached CRA’s Life Sciences Practice to assess the future market dynamics for a rare liver disease. A key...
    View engagement
  • 02
    Modeling the financial implications of innovative gene therapy business models
    Biotech client was looking to evaluate the financial implications of various innovative business models/strategic offerings for its novel gene therapy.
    View engagement

Contact a Cell & Gene Therapy expert.

See all Cell & Gene Therapy experts

Subscribe to receive our latest Insights.

Subscribe